"The U.S. Food and Drug Administration today granted accelerated approval to Perjeta (pertuzumab) as part of a complete treatment regimen for patients with early stage breast cancer before surgery (neoadjuvant setting). Perjeta is the first FDA-ap"...
Halaven Injection Patient Information including How Should I Take
In this Article
- What is eribulin (Halaven Injection)?
- What are the possible side effects of eribulin (Halaven Injection)?
- What is the most important information I should know about eribulin (Halaven Injection)?
- What should I discuss with my healthcare provider before taking eribulin (Halaven Injection)?
- How is eribulin given (Halaven Injection)?
- What happens if I miss a dose (Halaven Injection)?
- What happens if I overdose (Halaven Injection)?
- What should I avoid while receiving eribulin (Halaven Injection)?
- What other drugs will affect eribulin (Halaven Injection)?
- Where can I get more information?
What should I discuss with my healthcare provider before taking eribulin (Halaven Injection)?
You should not use eribulin if you are allergic to it.
To make sure you can safely take eribulin, tell your doctor if you have any of these other conditions:
- liver disease;
- kidney disease;
- slow heartbeats, congestive heart failure;
- heart rhythm disorder;
- personal or family history of Long QT syndrome; or
- an electrolyte imbalance (such as low levels of potassium or magnesium in your blood).
FDA pregnancy category D. Do not use eribulin if you are pregnant. It could harm the unborn baby. Use effective birth control, and tell your doctor if you become pregnant during treatment.
It is not known whether eribulin passes into breast milk or if it could harm a nursing baby. You should not breast-feed while you are using eribulin.
How is eribulin given (Halaven Injection)?
Eribulin is injected into a vein through an IV. You will receive this injection in a clinic or hospital setting.
Eribulin is usually given once per week for 2 weeks in a row, on days 1 and 8 of a 21-day treatment cycle. This 21-day cycle is then repeated until your doctor decides that eribulin is no longer an appropriate treatment for your condition. Follow your doctor's instructions.
Eribulin can lower blood cells that help your body fight infections. Your blood will need to be tested often. Your cancer treatments may be delayed based on the results of these tests. Your heart function may also need to be checked using an electrocardiograph or ECG (sometimes called an EKG). Visit your doctor regularly.
Additional Halaven Injection Information
- Halaven Injection Drug Interactions Center: eribulin iv
- Halaven Injection Side Effects Center
- Halaven Injection Overview including Precautions
- Halaven Injection FDA Approved Prescribing Information including Dosage
Bacteriostatic Water - User Reviews
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find support and advances in treatment.